⌘K
Loading ticker…
As of 2026-08-24, Ametek, Inc. (AME) has a 3-month relative strength percentile of 63 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.2%, relative volume 1.35×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AME is in a stage 2 uptrend, week 1. Currently in a 8-day base; basing ADR 1.9% (broad 2.1%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 0.6% / 8.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
AME is held by 2 ETFs as of Jun 2026. Top owner: PY at 0.98% weight, $2M notional.
Held by 244 ETFs · $8.4B across latest filings · largest weight 6.21% (SASS).
Top 2 by value, from SEC N-PORT-P filings dated Jun 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AME Jan avg: 3.37% median: 3.05% win: 75% σ: 4.46% n: 4 2022-04-12 → 2026-07-31 | AME Feb avg: 4.56% median: 4.69% win: 75% σ: 5.78% n: 4 2022-04-12 → 2026-07-31 | AME Mar avg: -3.82% median: -3.78% win: 50% σ: 6.86% n: 4 2022-04-12 → 2026-07-31 | AME Apr avg: -0.80% median: -2.79% win: 20% σ: 6.13% n: 5 2022-04-12 → 2026-07-31 | AME May avg: -0.04% median: -2.91% win: 40% σ: 4.89% n: 5 2022-04-12 → 2026-07-31 | AME Jun avg: 1.75% median: 1.24% win: 60% σ: 8.14% n: 5 2022-04-12 → 2026-07-31 | AME Jul avg: 3.29% median: 2.15% win: 60% σ: 5.58% n: 5 2022-04-12 → 2026-07-31 | AME Aug avg: -0.89% median: -0.71% win: 25% σ: 1.47% n: 4 2022-04-12 → 2026-07-31 (current) | AME Sep avg: -2.72% median: -2.62% win: 50% σ: 4.45% n: 4 2022-04-12 → 2026-07-31 | AME Oct avg: 5.97% median: 7.14% win: 75% σ: 7.90% n: 4 2022-04-12 → 2026-07-31 | AME Nov avg: 6.01% median: 7.93% win: 75% σ: 5.73% n: 4 2022-04-12 → 2026-07-31 | AME Dec avg: 0.20% median: 0.93% win: 50% σ: 6.03% n: 4 2022-04-12 → 2026-07-31 |